FDA generally does not regulate surveillance testing.
During this critical moment of the Covid-19 pandemic, improved testing procedures is fundamental.
Our ability to return to work, school, and “normal” life with confidence is predicated on non-invasive testing that yields immediate, reliable results. EasyRapidNow™ is a fast, reliable, affordable rapid nasal swab antigen test that is now available to businesses and brands through DermaCare Line. Our manufacturing partners are producing at a mass scale to keep up with unprecedented worldwide demand.
This is life-changing technology that will tackle the pandemic on all fronts – speed, ease-of-use, affordability, access, and reliability.
For Surveillance Use Only. NOT for use in diagnostic procedures (USA Only).
Coming Soon: We’re working on developing a mobile app, called VideoPassport® which works like a secure digital “boarding pass” that can be scanned prior to entering gathering places.
Disclosure: The test is under review by the FDA for approval by the FDA EUA. Results from Antigen testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status. EasyRapidNow™ is not affiliated with BinaxNow™ or Abbott Laboratories